Phibro Animal Health (PAHC) Invested Capital (2013 - 2026)

Phibro Animal Health has reported Invested Capital for 14 years, with the latest figure at $1.0 billion in Q2 2026.

• On a quarterly basis, Invested Capital rose 9.26% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 9.26% increase from a year earlier, with the FY2026 full-year figure at $1.0 billion, up 9.26% from the prior year.
• Invested Capital was $1.0 billion for Q2 2026 at Phibro Animal Health, up from $982.3 million in the prior quarter.
• The five-year high for Invested Capital was $1.0 billion in Q2 2026, with the low at $550.4 million in Q2 2022.
• Average Invested Capital over 5 years is $716.7 million, with a median of $598.3 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Invested Capital fell 8.01% in 2024, then soared 69.7% in 2025.
• Over 5 years, Invested Capital stood at $560.6 million in 2022, then advanced by 6.08% to $594.7 million in 2023, then surged by 48.97% to $885.9 million in 2024, then advanced by 7.98% to $956.6 million in 2025, then advanced by 4.77% to $1.0 billion in 2026.
• The last three Invested Capital figures came in at $1.0 billion (Q2 2026), $982.3 million (Q1 2026), and $956.6 million (Q4 2025), per Business Quant data.